Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazino-acethydrazone, a new hydrosoluble nitrofuran derivative. Studies on in vivo chemotherapeutic activity.
D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy*; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006835:Hydrazones / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009581:Nitrofurans / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011512:Proteus Infections / Q000188:drug therapy; D011514:Proteus vulgaris / Q000187:drug effects; D051381:Rats; D012486:Salmonella typhimurium / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013997:Time Factors; D001744:Urinary Bladder Calculi / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D006835:Hydrazones; D009581:Nitrofurans; D010879:Piperazines